Precision of the Icare200 for Measuring Intraocular Pressure
Estimation of the Precision of the Icare200 in the Measurement of Intraocular Pressure in Comparison to the Gold Standard : Goldmann Applanation Tonometer
2 other identifiers
interventional
171
1 country
1
Brief Summary
In adult patients, intraocular pression readings are often taken with an air puff tonometer or goldmann tonometer. The current gold standard for IOP measurement is the Goldmann Applanation Tonometry (GAT). In some patients, measurement of intraocular pressure taken by applanation or by air puff may prove to be impossible for various reasons (obesity, handicap, mental disorder, blindness for Air Puff Tonometry, Anxiety, etc). There are also many other devices that can be used to measure IOP, including those using rebound tonometry like the Icare 200. The rebound tonometer would systematize IOP screening because of its ease of use, provided its measurements are reliable. In this prospective study, investigators will be measuring participant's IOP with Goldmann Applanation Tonometry, Icare 200 Tonometer and Air Puff Tonometry to see if there is an agreement in IOP between the different devices. Investigators will also look if there is a concordance between central corneal thickness and IOP. Moreover, investigators will look if there is a IOP concordance between the 3 different devices for hight BMI people. Indeed, higher body mass index tend to have difficulties with proper positioning at the slit lamp that may lead to inaccurate GAT measurements. Additionally, stress level of the patients with different tonometry devices will be recorded using a visual analog scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedFirst Posted
Study publicly available on registry
December 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2022
CompletedJuly 25, 2022
July 1, 2022
5 months
November 29, 2021
July 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mean difference (mmHg) between the Icare200 rebound tonometer and the Goldmann applanation tonometer
To evaluate the concordance of Goldmann tonometer and Icare 200 tonometer
Day 0
Secondary Outcomes (4)
Diagnostic Performance
Day 0
Correlation between central corneal thickness and IOP
Day 0
Effect of BMI on IOP
Day 0
Patient comfort during tonometry
Day 0
Study Arms (1)
patients requiring an IOP (intra-Ocular Pression) measurement
EXPERIMENTALgroup representing adults patients in ophthalmologic consultation requiring an IOP measurement
Interventions
First, measurement of the eye pressure by air-puff tonometry and estimation of the pachymetries with the TONOREF III. Secondly, measurement of the eye pressure by GAT. Thirdly, measurement of the eye pressure by Icare 200.
Eligibility Criteria
You may qualify if:
- Adult man ou woman who consults in ophthalmology for a reason justifying an IOP measurement
- Able to give informed consent
- Being affiliated with a social security system
You may not qualify if:
- Participants who are unable to have IOP measured by Goldmann Tonometry
- Participants who are unable to have IOP measured by air puff Tonometry
- Age younger than 18 years
- Inability to sit
- Corneal ulcer
- Refractive surgery
- Corneal Astigmatism \>3D
- Participants who wear contact lenses
- Pregnancy
- Unable to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
Study Officials
- PRINCIPAL INVESTIGATOR
Adrien Coutu
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2021
First Posted
December 7, 2021
Study Start
December 1, 2021
Primary Completion
April 22, 2022
Study Completion
July 21, 2022
Last Updated
July 25, 2022
Record last verified: 2022-07